Sugi Predict

Sugi Predict / Compounds / Fluoride Ion

Fluoride Ion

Fluoride Ion

SCHEMBL1130679

C[SiH](C)[Zr+2](C1C=Cc2ccccc21)C1C=Cc2ccccc21.[F-].[F-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 2/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ SIGMAR1 Q99720 4/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ CCL2 P13500 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ DRD2 P14416 1/20 0.31
▸ ADRA2B P18089 1/20 0.31
▸ ADRA2C P18825 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ CHRM3 P20309 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride Ion SCHEMBL29898462 1.00 HTR2A (0.33) HTR2AHTR6SIGMAR1KDM4EBRD4
Bromide SCHEMBL29898437 0.96 HTR2A (0.37) HTR2AHTR6SIGMAR1KDM4EBRD4
Hydrochloric Acid SCHEMBL60273 0.96 HTR2A (0.33) HTR2AHTR6SIGMAR1KDM4EBRD4
Bromide SCHEMBL6910531 0.96 HTR2A (0.37) HTR2AHTR6SIGMAR1KDM4EBRD4
Iodide SCHEMBL29898384 0.96 HTR2A (0.33) HTR2AHTR6SIGMAR1KDM4EBRD4
SCHEMBL5838450 0.96 HTR2A (0.33) HTR2AHTR6SIGMAR1KDM4EBRD4
Hydrochloric Acid SCHEMBL723185 0.96 HTR2A (0.33) HTR2AHTR6SIGMAR1KDM4EBRD4
Hydrochloric Acid SCHEMBL6909128 0.95 HTR6 (0.33) HTR2AHTR6SIGMAR1KDM4EBRD4
Bromide SCHEMBL6910231 0.95 HTR2A (0.36) HTR2AHTR6SIGMAR1KDM4EBRD4
SCHEMBL6917721 0.95 HTR6 (0.33) HTR2AHTR6SIGMAR1KDM4EBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8298977-B2 Metallocene catalyst components supported on activating supports TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2012-10-30 — — US claimed
US-20100249347-A1 METALLOCENE CATALYST COMPONENTS SUPPORTED ON ACTIVATING SUPPORTS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-09-30 — — US claimed
EP-2024404-A1 METALLOCENE CATALYST COMPONENTS SUPPORTED ON ACTIVATING SUPPORTS Total Petrochemicals Research Feluy (BE) 2009-02-18 — — EP claimed
WO-2007131856-A1 METALLOCENE CATALYST COMPONENTS SUPPORTED ON ACTIVATING SUPPORTS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2007-11-22 — — WO claimed
EP-1857470-A1 Metallocene catalyst components supported on activating supports. TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2007-11-21 — — EP claimed
EP-1673401-B1 POLYMERIZATION PROCESS AND CONTROL OF POLYMER COMPOSITION PROPERTIES UNIVATION TECH LLC (US) 2015-10-21 — — EP disclosed
US-8298977-B2 Metallocene catalyst components supported on activating supports TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2012-10-30 — — US disclosed
EP-1546212-B1 BIMODAL POLYOLEFIN PRODUCTION PROCESS AND FILMS THEREFROM UNIVATION TECH LLC (US) 2011-02-16 — — EP disclosed
US-20100249347-A1 METALLOCENE CATALYST COMPONENTS SUPPORTED ON ACTIVATING SUPPORTS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-09-30 — — US disclosed
EP-2024404-A1 METALLOCENE CATALYST COMPONENTS SUPPORTED ON ACTIVATING SUPPORTS Total Petrochemicals Research Feluy (BE) 2009-02-18 — — EP disclosed
WO-2007131856-A1 METALLOCENE CATALYST COMPONENTS SUPPORTED ON ACTIVATING SUPPORTS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2007-11-22 — — WO disclosed
EP-1857470-A1 Metallocene catalyst components supported on activating supports. TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2007-11-21 — — EP disclosed
WO-2004047987-A1 METHODS OF FORMING A SUPPORTED ACTIVATED CATALYST COMPOSITION UNIVATION TECHNOLOGIES, LLC (US) 2004-06-10 — — WO disclosed
US-20040102312-A1 Methods of forming a supported activated catalyst composition UNIVATION TECHNOLOGIES, LLC 2004-05-27 — — US disclosed
WO-2004044010-A2 SYNTHESIS OF POLYMERIZATION CATALYST COMPONENTS UNIVATION TECHNOLOGIES, LLC (US) 2004-05-27 — — WO disclosed
US-20040092387-A1 Synthesis of polymerization catalyst components UNIVATION TECHNOLOGIES, LLC 2004-05-13 — — US disclosed
WO-2004022230-A1 PROCESS FOR PRODUCING FLUORINATED CATALYSTS UNIVATION TECHNOLOGIES, LLC (US) 2004-03-18 — — WO disclosed
WO-2004022607-A1 BIMODAL POLYOLEFIN PRODUCTION PROCESS AND FILMS THEREFROM UNIVATION TECHNOLOGIES, LLC (US) 2004-03-18 — — WO disclosed
US-20040044154-A1 Bimodal polyolefin production process and films therefrom UNIVATION TECHNOLOGIES, LLC 2004-03-04 — — US disclosed
US-20040043893-A1 Process for producing fluorinated catalysts UNIVATION TECHNOLOGIES, LLC 2004-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043893-A1 Process for producing fluorinated catalysts FLI1, AFF1, INF2 HTR2A 3132/4885HTR6 3619/4885SIGMAR1 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.